Here we present a novel co-solvent MD simulation method based on the lambda-dynamics simulation concept that aims to address a serious issue of current co-solvent simulation approaches, the limited chemical diversity of probe molecules ignoring the chemical context of the pharmacophoric feature represented by a probe. The new concept significantly increases the chemical diversity of functional groups investigated during co-solvent simulations. Application to four different test cases highlights the utility of the new approach to identify binding preferences of different functional groups and to correctly rank ligand series that differ by their substitution patterns.</div
Molecular Dynamics (MD) based computational co-solvent mapping methods involve the generation of an ...
Equilibrium simulations of molecular systems allow to extract many physicochemical properties. Given...
Co-solvent molecular dynamics (MD) simulations have recently become successful approaches in structu...
Cosolvent molecular dynamics (MD) simulations perform MD simulations of the protein in explicit wate...
Cosolvent molecular dynamics (MD) simulations perform MD simulations of the protein in explicit wate...
Early stage drug discovery would change dramatically if computational methods could accurately and q...
Probe mapping is a common approach for identifying potential binding sites in structure-based drug d...
While developing (self-assembled) MIPs, the selection of proper ligand molecules (or building blocks...
The dynamic and static properties of molecular dynamics simulations using various methods for treati...
The dynamic and static properties of molecular dynamics simulations using various methods for treati...
To ensure efficiency in discovery and development, the application of computational technology is es...
Molecular dynamics (MD) and related methods are close to becoming routine computational tools for dr...
Mixed-solvent molecular dynamics (MixMD) is a cosolvent mapping technique for structure-based drug d...
We report conventional and accelerated molecular dynamics simulations of α-Synuclein, designed to as...
Decades of hardware, methodological, and algorithmic development have propelled molecular dynamics (...
Molecular Dynamics (MD) based computational co-solvent mapping methods involve the generation of an ...
Equilibrium simulations of molecular systems allow to extract many physicochemical properties. Given...
Co-solvent molecular dynamics (MD) simulations have recently become successful approaches in structu...
Cosolvent molecular dynamics (MD) simulations perform MD simulations of the protein in explicit wate...
Cosolvent molecular dynamics (MD) simulations perform MD simulations of the protein in explicit wate...
Early stage drug discovery would change dramatically if computational methods could accurately and q...
Probe mapping is a common approach for identifying potential binding sites in structure-based drug d...
While developing (self-assembled) MIPs, the selection of proper ligand molecules (or building blocks...
The dynamic and static properties of molecular dynamics simulations using various methods for treati...
The dynamic and static properties of molecular dynamics simulations using various methods for treati...
To ensure efficiency in discovery and development, the application of computational technology is es...
Molecular dynamics (MD) and related methods are close to becoming routine computational tools for dr...
Mixed-solvent molecular dynamics (MixMD) is a cosolvent mapping technique for structure-based drug d...
We report conventional and accelerated molecular dynamics simulations of α-Synuclein, designed to as...
Decades of hardware, methodological, and algorithmic development have propelled molecular dynamics (...
Molecular Dynamics (MD) based computational co-solvent mapping methods involve the generation of an ...
Equilibrium simulations of molecular systems allow to extract many physicochemical properties. Given...
Co-solvent molecular dynamics (MD) simulations have recently become successful approaches in structu...